Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by Str8Shuteron Nov 20, 2020 12:53pm
98 Views
Post# 31941523

RE:RE:RE:RE:RE:IR

RE:RE:RE:RE:RE:IRThat is indeed a fair question.  I think that the key here is that if someone wanted to buy a few thousand or tens of thousands of shares, they could grab some right now at a good price.  A few at a time, if they are patient.  The risk is that the SP elevates in the meantime, raising their ACB, and possibly even resulting in the proverbial "missing the boat" if a positive NR occurs in the meantime before they are able to buy all the shares that they really wanted.

However, if a serious Accredited investor wanted to grab a serious number of shares in the short term, at a guaranteed set price, the best way to do so would be via the Offering because there are millions of shares available, as outlined in the Prospectus.

At least, that's my two cents.  GLTA!

Bully88 wrote: Genuine question/ concern here,

Do major institutions invest in a PP at a certain price if the stock is strading .10 - .15 cents below the offering?

if an institution has agreed to buy at a certain price but the shares go down the way they have today, do they have the option to back out and just buy at the lower price?

would this be a risk of not having anybody participate in the offering?

thank you for your informed, eductated responces.

Cheers,

Bully




<< Previous
Bullboard Posts
Next >>